$HIT

Hayes Timothy sold $16K of HIT

Hayes Timothy sold 17,730 shares of Health In Tech, Inc. (HIT) at an average of $0.92 ($0.91–$0.93) across 2 trades over 2026-09-09 to 2026-09-11.

Original reporting
SEC EDGAR · Hayes Timothy
Published Sep 12, 2026, 1:14 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 12, 2026, 1:31 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$HIT
Neutral
high confidence
Mentioned
$HIT
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HITNeutralLow
01

Why it matters

The sale is unlikely to affect the stock price materially.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

Potential upcoming financing or dilution not disclosed.

Relevance 3/10Novelty 2/10Timing: filed 2026-09-11

Background

Form 4 filings disclose insider transactions; this one reports a modest sale by a director.

Company-level read

Ticker impact

$HITNeutralHigh confidence
Context

Director Timothy Hayes sold 17,730 shares (~$16K) of Health In Tech, Inc. in a Form 4 filing.

Expected impact

No significant move expected.

Evidence & confidence

The transaction size is trivial relative to market cap and does not signal a change in insider confidence.

Market effects

None

None

None

Counterpoint

Even small insider sales can precede larger moves if multiple insiders sell.

Key entities

  • Health In Tech, Inc.

    Issuer of the Form 4 filing.

  • Hayes Timothy

    Director and insider who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$HITMedAI 8/10

Health In Tech Reports Second Quarter 2026 Financial Results

Health In Tech (Nasdaq: HIT) reported Q2 2026 revenue of $8.1M versus $9.3M in Q2 2025, and first-half 2026 revenue of $16.8M versus $17.3M. Contracted revenue was $32.3M as of June 30, 2026, and pipeline revenue was $66.3M as of July 31, 2026. Net loss was $2.5M. The company reaffirmed 2026 revenue guidance of $45M to $50M.

$HITMed

Health In Tech Reports Second Quarter 2026 Financial Results

Health In Tech, Inc. (HIT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Health In Tech Reports Second Quarter 2026 Financial Results Contracted Revenue of $32.3 Million as of June 30, 2026 Pipeline Revenue of $66.3 Million as of July 31, 2026 Distribution Partners Grew 19.9% Year Over Year Stuart, FL., August 13, 2026 /PRNewswire/ — Heal

$HITMed

L&T, Hitachi Energy consortium signs Rs 15,000 crore+ framework pact with TenneT for offshore renewable project

According to L&T, it and Hitachi Energy formed a consortium with TenneT to sign a framework pact worth over Rs 15,000 crore for offshore renewable integration under TenneT’s 2 GW HVDC programme. L&T will handle EPC for converter platforms and infrastructure, while Hitachi Energy will supply HVDC Light. The scope covers four projects totaling 8 GW transmission capacity in the Netherlands and Germany.

$HITMedAI 8/10

Sensex Today | Stock Market Live: Sensex, Nifty trade marginally higher; Adani Power, Hitachi Energy, Vedanta most active

Indian benchmarks Sensex and Nifty were marginally higher, with Adani Power, Hitachi Energy and Vedanta among the most active. The report also cites company updates: ONGC selected a BP Plc subsidiary as a technical service provider for the WO basin, with estimated production gains and a fixed fee plus revenue-linked service fees. Venus Pipes & Tubes began commercial operations of a fittings facility and added 4,200 MTPA seamless capacity (total 6,000 MTPA).